No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9502168 |
chr6:4371622-4371623 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs76926903 |
chr6:4371649-4371650 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs560953762 |
chr6:4371659-4371660 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs114574401 |
chr6:4371670-4371671 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs546508701 |
chr6:4371693-4371694 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs560434405 |
chr6:4371707-4371708 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs532188522 |
chr6:4371826-4371827 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs147841050 |
chr6:4371886-4371887 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs117292204 |
chr6:4371891-4371892 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs115505519 |
chr6:4371896-4371897 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs548162825 |
chr6:4371942-4371943 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs116332457 |
chr6:4371947-4371948 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs139477784 |
chr6:4371985-4371986 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs553686911 |
chr6:4372020-4372021 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs573507620 |
chr6:4372021-4372022 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs373432039 |
chr6:4372026-4372027 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs563079968 |
chr6:4372033-4372034 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs559145332 |
chr6:4372062-4372063 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs73717307 |
chr6:4372069-4372070 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs544301170 |
chr6:4372127-4372128 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs180967143 |
chr6:4372170-4372171 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs574480339 |
chr6:4372203-4372204 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs548785520 |
chr6:4372221-4372222 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs373483950 |
chr6:4372228-4372229 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs375421928 |
chr6:4372247-4372248 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs548504097 |
chr6:4372334-4372335 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs532479256 |
chr6:4372335-4372336 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs568625363 |
chr6:4372387-4372388 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs562706563 |
chr6:4372436-4372437 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs531406731 |
chr6:4372501-4372502 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs548320533 |
chr6:4372555-4372556 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs568194744 |
chr6:4372663-4372664 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs369611658 |
chr6:4372668-4372669 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs114882033 |
chr6:4372724-4372725 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs199726433 |
chr6:4372728-4372729 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs547414475 |
chr6:4372752-4372753 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs567041490 |
chr6:4372769-4372770 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs9504064 |
chr6:4372852-4372853 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs185150372 |
chr6:4372882-4372883 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs558835178 |
chr6:4372893-4372894 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs568218490 |
chr6:4372990-4372991 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs145005163 |
chr6:4373006-4373007 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs144963727 |
chr6:4373009-4373010 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs570155115 |
chr6:4373024-4373025 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs574641809 |
chr6:4373078-4373079 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs190431084 |
chr6:4373101-4373102 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs539132095 |
chr6:4373102-4373103 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs556013157 |
chr6:4373196-4373197 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs9405232 |
chr6:4373213-4373214 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs377747326 |
chr6:4373238-4373239 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|